Net sales and profits were both up in fiscal 2015. Net sales were 49,387 million yen, up 2.4% year on year, operating income was 7,588 million yen, up 7.4%, ordinary income was 8,091 million yen, up 7.7%, and net income was 4,890 million yen, up 12.4%. Business results were driven by a solid performance in the Cosmetics segment. The Group posted record-high earnings at every level of profit. The operating income margin was 15.4%.
Year ended September 30, 2015
Year ended September 30, 2014
YoY change
Total value
As percentage of sales
Total value
As percentage of sales
Millions of yen
%
Millions of yen
%
Millions of yen
%
Net sales
49,387
100.0
48,253
100.0
+1,133
+2.4
Cost of sales
16,800
34.0
16,523
34.2
+276
+1.7
Gross profit
32,587
66.0
31,730
65.8
+857
+2.7
SG&A
24,999
50.6
24,666
51.1
+333
+1.4
Operating income
7,588
15.4
7,064
14.6
+523
+7.4
Non-operating income/expenses
503
‐
449
‐
+54
‐
Ordinary income
8,091
16.4
7,513
15.6
+578
+7.7
Extraordinary income/loss
(14)
‐
(54)
‐
+40
‐
Income before income taxes
8,077
‐
7,458
‐
+618
‐
Income taxes
3,149
‐
3,098
‐
+51
‐
Net income
4,890
9.9
4,349
9.0
+541
+12.4
EPS
¥136.79
¥116.16
ROE
8.9%
8.0％
Dividend per share / dividend payout ratio
¥100/73.1%
¥60/51.7%
* Ordinary annual dividends per share are forecast at 100 yen in fiscal 2016.
In the Cosmetics segment, net sales and segment income both rose year on year on the back of aggressive spending on marketing and the launch of new products.
In the Pharmaceuticals & Health Food segment, net sales fell while segment income rose year on year, with the streamlining of SG&A expenses making up for sluggish functional drink sales.
In the Other segment, net sales fell and the segment loss increased year on year
Noevir Holdings Co., Ltd. is a Japan-based company engaged in the manufacture and sale of cosmetics, toiletries, pharmaceuticals and foods, as well as the purchase and sale of cosmetic products. The Company operates in three business segments. The Cosmetics segment is engaged in the manufacture and sale of cosmetics and toiletries, as well as the purchase and sale of cosmetic products. The Pharmaceuticals and Foods segment is engaged in the manufacture and sale of general drugs and foods. The Others segment is engaged in the purchase and sale of apparels, body fashion, aircrafts and vessels, as well as air transportation business.
NOEVIR HOLDINGS CO., LTD. 
